Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Lilly

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lilly's 2013 sales performance.

Lilly

Detecting Alzheimer’s ahead of a cure

Detecting Alzheimer’s ahead of a cure

Digital detection. One such promising study comes from Eli Lilly, in partnership with Apple and Evidation Health. ... According to Divakar Ramakrishnan, Lilly’s chief digital officer, the findings from this study “could inform subsequent research

Novartis eyes potential new indication for Cosentyx

Novartis eyes potential new indication for Cosentyx This includes Johnson &Johnson’s Tremfya (guselkumab), AbbVie’s Skyrizi (risankizumab), Eli Lilly’s Taltz (ixekizumab) and Pfizer’s Xeljanz (tofacitinib citrate).

J&J's Tremfya filed for approval in US for psoriatic arthritis

J&J's Tremfya filed for approval in US for psoriatic arthritis This includes Novartis’ Consentyx (secukinumab), AbbVie’s Skyrizi (risankizumab), Eli Lilly’s Taltz (ixekizumab) and Pfizer’s Xeljanz (tofacitinib citrate) , which are all already approved in psoriatic arthritis. ... However, J&J has been subject

Biogen and Eisai drop Alzheimer’s drug elenbecestat

Biogen and Eisai drop Alzheimer’s drug elenbecestat Merck &Co/MSD, Janssen and Eli Lilly have all reported similar patterns in earlier failed candidates in the category.

FDA fast-tracks AstraZeneca’s Farxiga in heart failure

FDA fast-tracks AstraZeneca’s Farxiga in heart failure It also renews hope for the pharma company that it can chase down SGLT2 market leader Jardiance (empagliflozin) from Eli Lilly and Boehringer Ingelheim.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics